Be part of our team

Tubulis is developing new antibody-drug-conjugates (ADCs) aimed at treating cancer. Based on state-of-the art ADC technology platforms TubTag® and Tubutecan® Tubulis is a global leader in ADC development. With two programs in clinical development phase I/IIa, and a promising pipeline with new clinical candidates as well as new core technologies at the horizon Tubulis is now looking for a highly motivated European patent attorney who is seeking an opportunity to build up a strong IP estate in a rapidly developing and densely crowded field. 

You will report directly into the Global Head of IP. It is expected that the team will grow significantly over the next years. 

Your mission

• all IP aspects of one of Tubulis’ clinical candidates
• all IP aspects of one of Tubulis’ core technologies
• invention harvesting and drafting patent applications
• FTO analyses
• publication review
• patent prosecution worldwide in close collaboration with external law firms
• opposition and appeal proceedings before the EPO and similar proceedings worldwide
• further developing the infrastructure of the IP department, including file and information management

Your profile

Qualifications:

• PhD in chemistry or biochemistry
• Fully qualified European Patent Attorney 
• 1 to 3 years of experience in industry or private practice
• Business fluent English

Preferred Qualifications:

• German Patent Attorney or similar qualification in another major European country
• European Patent Litigator
• Experience in data mining

Why us?

At Tubulis, curiosity and innovation drive us to transform cancer treatment. We are a fast-growing biotech where science meets passion—and where you have the chance to grow with us.

• Impact that matters: Contribute to breakthrough therapies.
• Global mindset: Work in an international, diverse team.
• Grow & thrive: Develop your career in a supportive, fast-moving environment.
• Innovation every day: Push boundaries with cutting-edge science.

At Tubulis, your ideas matter, your growth matters—and together, we make a difference.

About us

The development of novel, effective and safe therapies for the treatment of cancer is one of the main challenges for modern medicine. We want to drive this process forward. The main goal of Tubulis is to become a leading company in the field of targeted therapeutics and antibody-drug conjugates (ADCs). With a strong team, our own technologies and innovative therapeutic concepts, we are ushering in a new era in the ongoing fight against cancer and share the vision of helping patients world-wide. Be part of a multidisciplinary and focused team, that works towards getting novel promising ADCs to patients with solid and hematological cancers.